Aleph Blog

 Subscribe in a reader

Disclosure

This blog is produced by David Merkel CFA, a registered representative of Finacorp Securities as an outside business activity. As such, Finacorp Securities does not review or approve materials presented herein. By viewing or participating in discussion on this blog, you understand that the opinions expressed within do not reflect the opinions or recommendations of Finacorp Securities, but are the opinions of the author and individual participants. Neither the information nor any opinion expressed constitutes a solicitation for the purchase or sale of any security or other instrument. Before investing, consider your investment objectives, risks, charges and expenses. Any purchase or sale activity in any securities instrument should be based upon your own analysis and conclusions. Past performance is not indicative of future results. Finacorp Securities is a member FINRA and SIPC.

David Merkel

At my blog there are two main purposes: teaching investors about better investing through risk control, and tying all of the markets into a coherent whole.

Latest



Archives


Categories


  • Recent Comments:

    • matt: I can’t wait to read your piece on mutual banks.
    • retail_guy: David- I absolutely love the Bicycle versus Table stability concept. It is elegant in its simplicity.
    • KevinMorrow: Mr. Merkel, I’ve been an avid reader of your blob since picking up some of your thoughts from the...
    • Mcwop: My (and others) current hypothesis, which still needs vetting, is that during this crisis banks are buying...
    • Mcwop: Here are my current positions, most opened up in the past month. Cost basis in paren. APPLE INC (91.85) BANK...
  • Recent Trackbacks:

  •  Subscribe in a reader

     Subscribe in a reader (comments)

    Subscribe to RSS Feed

    Enter your Email


    Preview | Powered by FeedBlitz

    Seeking Alpha Certified

    InstantBull.com: Bull, Boards & Blogs

    Blog Directory - Blogged

    IStockAnalyst

    Advertising


    blog advertising is good for you

    Books I Have Reviewed

    Book Reviews

    Other Advertising

     

    Triage, Part 2

    In the first round of triage I went through the first third of my portfolio. Now is the time for the second third; definitely a more positive experience, together with my changes on the first third, after further reflection.
    The Dead — Companies with bad balance sheets, but have been whacked so bad that it is still worth playing

    • Jones Apparel
    • Deerfield Capital

    If they rally a lot more, I am out.

    Walking Wounded — Companies with okay balance sheets that we feed more cash to

    • Lafarge
    • Industrias Bachoco
    • YRC Worldwide [moved from The Dead]

    Seemingly healthy that might have financing problems — Sold

    • Lithia Automotive
    • Group 1 Automotive

    Uncertain as of yet

    Sara Lee

    Don’t know what to do here. Balance sheet has issues but profitability is improving as the turnaround progresses.

    Healthy companies that we leave alone

    • Barclays plc (Moved from Uncertain as of yet — Capital levels are seemingly adequate.)
    • Deutsche Bank
    • Mylan Labs
    • Cimarex Energy
    • Nam Tai
    • Arkansas Best
    • Bronco Drilling
    • Vishay Intertechnology
    • Aspen Holdings
    • Safety Insurance
    • Lincoln National
    • Assurant

    Safe New Names Bought

    • PartnerRe
    • National Atlantic [Did not get a full position on, was too stubborn about levels... not buying here.]

    So, there’s the triage with one third to go — I have not done the companies with my largest gains, which I presume to be in better shape. At this point, I’m relatively happy with what I have.

    PS — As to my methods, the main parts are reviews of the balance sheets and cash flow statements. It’s basic bond analysis, asking how likely it is that future cash flows will be able to cover the debts in question. At present, I am looking to hold companies that can survive a crisis. With the reservations noted above, most of this portfolio can do so.
    Full Disclosure: Long JNY DFR LR IBA YRCW SLE BCS DB MYL XEC NTE ABFS BRNC VSH AHL AIZ LNC SAFT PRE NAHC

    One Response to “ Triage, Part 2 ”

    1. PaulinKansasCity Says:

      I did not get a chance to add appreciably more to my NAHC at $9.25. $2 higher and I lighten; $2 lower and I add. i like XEC; really cheap (it always seems to stay that way though!). Greta work David and as always thanks for sharing your thoughts.

    Leave a Reply